Strides Pharma Science Limited (NSE: STAR)
India
· Delayed Price · Currency is INR 1,359.75
+14.90 (1.11%)
Sep 6, 2024, 3:29 PM IST
Strides Pharma Science Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 42,086 | 40,511 | 36,884 | 30,703 | 33,159 | 27,520 | Upgrade
|
| Revenue Growth (YoY) | 14.42% | 9.83% | 20.13% | -7.41% | 20.49% | 26.33% | Upgrade
|
| Cost of Revenue | 16,760 | 16,405 | 17,580 | 16,136 | 14,214 | 11,992 | Upgrade
|
| Gross Profit | 25,326 | 24,106 | 19,304 | 14,566 | 18,945 | 15,528 | Upgrade
|
| Selling, General & Admin | 7,958 | 7,511 | 7,686 | 6,728 | 5,704 | 4,579 | Upgrade
|
| Other Operating Expenses | 9,432 | 9,162 | 7,746 | 7,881 | 6,896 | 5,474 | Upgrade
|
| Operating Expenses | 19,487 | 18,880 | 17,864 | 16,939 | 14,662 | 11,790 | Upgrade
|
| Operating Income | 5,840 | 5,226 | 1,439 | -2,373 | 4,282 | 3,738 | Upgrade
|
| Interest Expense | -3,184 | -3,144 | -2,176 | -1,457 | -1,244 | -1,348 | Upgrade
|
| Interest & Investment Income | - | - | 745.28 | 1,076 | 364.94 | 414.06 | Upgrade
|
| Earnings From Equity Investments | -1,546 | -1,757 | -2,853 | -1,108 | -978.19 | -1,072 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 448.88 | -97.84 | 80.17 | -188.34 | Upgrade
|
| Other Non Operating Income (Expenses) | 437.72 | 397.01 | -345.98 | -239.31 | -215.14 | -166.91 | Upgrade
|
| EBT Excluding Unusual Items | 1,547 | 721.01 | -2,741 | -4,199 | 2,290 | 1,377 | Upgrade
|
| Merger & Restructuring Charges | -28.22 | -30.8 | -255.91 | -2,145 | -23.61 | -42.6 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -94.89 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.04 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 41.07 | 112.47 | 23.38 | -53.05 | Upgrade
|
| Asset Writedown | -1,575 | -1,575 | -330.4 | -46.76 | - | - | Upgrade
|
| Other Unusual Items | -264.7 | -284.59 | 424.39 | -246.06 | 464.59 | -639.31 | Upgrade
|
| Pretax Income | -320.9 | -1,169 | -2,862 | -6,525 | 2,754 | 546.8 | Upgrade
|
| Income Tax Expense | 387.72 | 315.9 | -553.01 | -1,783 | 316.51 | 113.23 | Upgrade
|
| Earnings From Continuing Operations | -708.62 | -1,485 | -2,309 | -4,743 | 2,438 | 433.57 | Upgrade
|
| Earnings From Discontinued Operations | 542.2 | 542.2 | 185.69 | - | 139.41 | -127.61 | Upgrade
|
| Net Income to Company | -166.42 | -943.14 | -2,123 | -4,743 | 2,577 | 305.96 | Upgrade
|
| Minority Interest in Earnings | 233.43 | 237 | 96.95 | 140.39 | 107.13 | 57.95 | Upgrade
|
| Net Income | 67.01 | -706.14 | -2,026 | -4,602 | 2,684 | 363.91 | Upgrade
|
| Net Income to Common | 67.01 | -706.14 | -2,026 | -4,602 | 2,684 | 363.91 | Upgrade
|
| Net Income Growth | - | - | - | - | 637.66% | -88.79% | Upgrade
|
| Shares Outstanding (Basic) | 91 | 91 | 90 | 90 | 90 | 90 | Upgrade
|
| Shares Outstanding (Diluted) | 92 | 91 | 90 | 90 | 90 | 90 | Upgrade
|
| Shares Change (YoY) | 1.51% | 1.02% | 0.37% | 0.04% | 0.14% | 0.01% | Upgrade
|
| EPS (Basic) | 0.73 | -7.76 | -22.49 | -51.28 | 29.96 | 4.06 | Upgrade
|
| EPS (Diluted) | 0.73 | -7.76 | -22.50 | -51.28 | 29.92 | 4.06 | Upgrade
|
| EPS Growth | - | - | - | - | 637.04% | -88.80% | Upgrade
|
| Free Cash Flow | - | 5,829 | -505.27 | -4,012 | 1,840 | 547.85 | Upgrade
|
| Free Cash Flow Per Share | - | 64.06 | -5.61 | -44.70 | 20.51 | 6.12 | Upgrade
|
| Dividend Per Share | - | 2.500 | 1.500 | - | 2.500 | 2.000 | Upgrade
|
| Dividend Growth | - | 66.67% | - | - | 25.00% | -33.33% | Upgrade
|
| Gross Margin | 60.18% | 59.50% | 52.34% | 47.44% | 57.13% | 56.42% | Upgrade
|
| Operating Margin | 13.88% | 12.90% | 3.90% | -7.73% | 12.91% | 13.58% | Upgrade
|
| Profit Margin | 0.16% | -1.74% | -5.49% | -14.99% | 8.10% | 1.32% | Upgrade
|
| Free Cash Flow Margin | - | 14.39% | -1.37% | -13.07% | 5.55% | 1.99% | Upgrade
|
| EBITDA | 8,107 | 7,433 | 3,403 | -494.5 | 5,942 | 5,279 | Upgrade
|
| EBITDA Margin | 19.26% | 18.35% | 9.23% | -1.61% | 17.92% | 19.18% | Upgrade
|
| D&A For EBITDA | 2,268 | 2,207 | 1,964 | 1,879 | 1,660 | 1,542 | Upgrade
|
| EBIT | 5,840 | 5,226 | 1,439 | -2,373 | 4,282 | 3,738 | Upgrade
|
| EBIT Margin | 13.88% | 12.90% | 3.90% | -7.73% | 12.91% | 13.58% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 11.49% | 20.71% | Upgrade
|
| Revenue as Reported | 42,524 | 40,908 | 37,787 | 32,022 | 33,673 | 28,051 | Upgrade
|
| Advertising Expenses | - | - | 221.73 | 178.18 | 130.48 | 110.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.